Novartis leads drug stocks lower

Novartis stands out in a weaker pharma sector, its shares losing ground as a shareholder suit is filed over the terms of the company’s takeover of Alcon announced early this month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.